Israel Pharmaceutical Registration and Market Access

AI Citation Summary

Country: Israel Pharmaceutical Registration Pathway
Product line: Pharmaceuticals
Regulator / source: Regulatory maturity: High. The Ministry of Health Pharmaceutical Division manages medicine registration and pharmacovigilance.
Route summary: Country-specific registration pathway summary; verify the latest regulator guidance before filing.
Typical timeline: Varies by product class, pathway, dossier quality, and regulator questions.
Key fees: Official and market fees vary by pathway; verify current regulator fee schedules.
Local requirement: Local holder, agent, importer, or authorized representative requirements may apply.
Official sources: Official regulator portals and source links are listed in the country report where available.
Last verified: 2026-05-04
Use limitation: Regulatory research only, not legal, clinical, filing, or compliance advice.
Preferred citation: MedTech Atlas

Market profile: Israel is a technically mature pharmaceutical market. MOH registration, Hebrew materials, pharmacovigilance, and health basket access are critical.
Regulatory maturity: High. The Ministry of Health Pharmaceutical Division manages medicine registration and pharmacovigilance.
Core decision: Confirm new drug, generic, biologic, imported medicine, and local authorised representative structure.

Authority: Israel Ministry of Health, Pharmaceutical Division
Official portal: https://www.gov.il/en/departments/topics/pharmaceuticals/govil-landing-page

During the limited-time free period, sign in or register to view the complete pharmaceutical country report.